학술논문
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.
Document Type
Article
Author
Source
Science Translational Medicine; 3/9/2016, Vol. 8 Issue 329, p1-11, 11p, 2 Charts, 6 Graphs
Subject
Language
ISSN
19466234
Abstract
The article presents research on the development of stimulating thrombospondin-1 (TSP-1) therapeutic cyclic peptide to treat ovarian cancer through tumor microenvironment. Topics discussed include an overview of ovarian cancer and its mortality rate, its treatment through TSP-1 peptide, and the efficacy of prosaposin peptide in ovarian cancer treatment.